Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2022, Vol. 16 Issue (1) : 10-16    https://doi.org/10.1007/s11684-021-0889-7
REVIEW
Laboratory diagnosis for malaria in the elimination phase in China: efforts and challenges
Jianhai Yin(), Mei Li, He Yan, Shuisen Zhou, Zhigui Xia()
National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research); NHC Key Laboratory of Parasite and Vector Biology; WHO Collaborating Center for Tropical Diseases; National Center for International Research on Tropical Diseases, Shanghai 200025, China
 Download: PDF(174 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

Malaria remains a global health challenge, although an increasing number of countries will enter pre-elimination and elimination stages. The prompt and precise diagnosis of symptomatic and asymptomatic carriers of Plasmodium parasites is the key aspect of malaria elimination. Since the launch of the China Malaria Elimination Action Plan in 2010, China has formulated clear goals for malaria diagnosis and has established a network of malaria diagnostic laboratories within medical and health institutions at all levels. Various external quality assessments were implemented, and a national malaria diagnosis reference laboratory network was established to strengthen the quality assurance in malaria diagnosis. Notably, no indigenous malaria cases have been reported since 2017, but the risk of re-establishment of malaria transmission cannot be ignored. This review summarizes the lessons about malaria diagnosis in the elimination phase, primarily including the establishments of laboratory networks and quality control in China, to better improve malaria diagnosis and maintain a malaria-free status. A reference is also provided for countries experiencing malaria elimination.

Keywords malaria      laboratory diagnosis      quality control      malaria elimination      China     
Corresponding Author(s): Jianhai Yin,Zhigui Xia   
Just Accepted Date: 19 January 2022   Online First Date: 25 February 2022    Issue Date: 28 March 2022
 Cite this article:   
Jianhai Yin,Mei Li,He Yan, et al. Laboratory diagnosis for malaria in the elimination phase in China: efforts and challenges[J]. Front. Med., 2022, 16(1): 10-16.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-021-0889-7
https://academic.hep.com.cn/fmd/EN/Y2022/V16/I1/10
Year A proportion of institutions can ?perform blood tests for malaria ?parasite Annual blood examination ?for malaria parasites in patients ?with clinically diagnosed ?malaria, suspected malaria, ?and unexplained fever Laboratory test Malaria screening by entry–?exit inspection and quarantine ?agencies
By 2012 General hospitals and CDCs at ?the provincial, prefecture level ?reach 100%
General hospitals and CDCs in ?the Category I, II, and III ?counties reach 100%
Township medical institutions ?in Category I and II counties ?reach 90%
Not be less than 2% and 1% ?of the population in the ?jurisdiction of towns and ?townships in Category I and ?II counties, respectively
Not be less than 2‰ of the ?population in the jurisdiction? of Category III counties
Tests in the malaria ?transmission season should ?not be less than 80%
Laboratory test rate of malaria ?cases reaches 100%
Laboratory confirmed rate ?reaches 75%
100% of fever patients entering ?from overseas malaria endemic ?areas
By 2015 General hospitals and CDCs at ?the provincial, prefecture level ?remain 100%
General hospitals and CDCs in ?the Category I, II, and III ?counties remain 100%
Township medical institutions ?in Category I and II counties ?reach 100%
Not be less than 1% and 2‰ of ?the population in the jurisdiction ?of towns and townships in ?Category I and II counties, ?respectively
Not be less than 2‰ of the ?population in the jurisdiction ?of Category III counties
Tests in the malaria ?transmission season should ?not be less than 80%
Laboratory confirmed rate ?reaches 100% 100% of fever patients entering ?from overseas malaria endemic ?areas
By 2020 Medical and health institutions ?and CDCs at the county level ?and above in the original ?endemic counties all have ?facilities and capabilities ?for blood testing of malaria ?parasites All people suspected of malaria ?get a laboratory blood test for ?malaria parasites; malaria cases ?whose source of infection cannot ?be determined by epidemiology ?should be genetically traced and ?identified by national laboratories
Tab.1  Objectives of blood tests for Plasmodium in fever patients in China Malaria Elimination Action Plan (2010–2020)
Fig.1  Trends of proportion of clinically diagnosed and unclassified cases in the total malaria cases reported in China, 2010–2020.
Definition Diagnostic Criteria for Malaria (WS259-2006) Diagnosis of Malaria (WS259-2015)
Carrier Asymptomatic
Test positive: microscopy
Suspected case Epidemiological history of malaria
Atypical symptoms of malaria
Clinically diagnosed case Epidemiological history of malaria
Typical symptoms of malaria, or atypical symptoms of ?malaria; and presumptive treatment is effective
History
Typical symptoms of malaria, or atypical symptoms of ?malaria
Confirmed case Epidemiological history of malaria
Clinical manifestations
Test positive: microscopy and/or RDTs
Clinically diagnosed case
Test positive: microscopy and/or RDTs and/or NAATsa
Asymptomatic infection Asymptomatic
Test positive: microscopy and/or RDTs and/or NAATs
Severe case Confirmed case
Severe symptoms
Tab.2  Definition of malaria cases and infections in the diagnostic criteria
1 WHO. World malaria report 2020: 20 years of global progress and challenges. Geneva: World Health Organization, 2020
2 WHO. World malaria report 2019. Geneva: World Health Organization, 2019
3 LH Tang, LQ Xu, YD Chen. Parasitic Disease Control and Research in China. Beijing: Beijing Science & Technology Press, 2012 (in Chinese)
4 JH Yin, SS Zhou, ZG Xia, RB Wang, YJ Qian, WZ Yang, XN Zhou. Historical patterns of malaria transmission in China. Adv Parasitol 2014; 86: 1–19
https://doi.org/10.1016/B978-0-12-800869-0.00001-9 pmid: 25476879
5 Ministry of Health, the People’s Republic of China. China Malaria Elimination Action Plan (2010–2020). 2010 (in Chinese)
6 L Zhang, J Feng, SS Zhang, ZG Xia, SS Zhou. The progress of national malaria elimination and epidemiological characteristics of malaria in China in 2017. Chin J Parasitol Parasit Dis (Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi) 2018; 36(3): 201–209 (in Chinese)
7 WHO. From 30 million cases to zero: China is certified malaria-free by WHO.
8 malERA Consultative Group on Diagnoses and Diagnostics. A research agenda for malaria eradication: diagnoses and diagnostics. PLoS Med 2011; 8(1): e1000396
https://doi.org/10.1371/journal.pmed.1000396 pmid: 21311583
9 WHO. Universal access to malaria diagnostic testing: an operational manual. Geneva: World Health Organization, ‎2011
10 J Yin, L Zhang, J Feng, S Zhou, Z Xia. Malaria diagnosis and verification—China, 2017–2018. China CDC Wkly 2020; 2(17): 285–288
https://doi.org/10.46234/ccdcw2020.073 pmid: 34594640
11 JH Yin, H Yan, F Huang, M Li, HH Xiao, SS Zhou, ZG Xia. Establishing a China malaria diagnosis reference laboratory network for malaria elimination. Malar J 2015; 14(1): 40
https://doi.org/10.1186/s12936-015-0556-z pmid: 25628071
12 J Yin, H Yan, M Li, Y Ruan, X Zhang, L Wang, C Cao, Z Xia, S Zhou. Competency and challenges in malaria microscopy in China. Biosci Trends 2017; 11(6): 702–705
https://doi.org/10.5582/bst.2017.01275 pmid: 29311452
13 National Institute of Parasitic Diseases, China CDC. The pre-review of the provincial reference laboratory for malaria diagnosis in Ningxia. (in Chinese) (accessed November 3, 2020)
14 SS Zhou, Y Wang, Y Li. Malaria situation in the People’s Republic of China in 2010. Chin J Parasitol Parasit Dis (Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi) 2011; 29(6): 401–403 (in Chinese)
pmid: 24822335
15 ZG Xia, MN Yang, SS Zhou. Malaria situation in the People’s Republic of China in 2011. Chin J Parasitol Parasit Dis (Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi) 2012; 30(6): 419–422 (in Chinese)
pmid: 23484249
16 ZG Xia, J Feng, SS Zhou. Malaria situation in the People’s Republic of China in 2012. Chin J Parasitol Parasit Dis (Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi) 2013; 31(6): 413–418 (in Chinese)
pmid: 24818404
17 L Zhang, J Feng, ZG Xia. Malaria situation in the People’s Republic of China in 2013. Chin J Parasitol Parasit Dis (Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi) 2014; 32(6): 407–413 (in Chinese)
pmid: 25902667
18 G Ding, G Zhu, C Cao, P Miao, Y Cao, W Wang, Y Gu, S Xu, S Wang, H Zhou, J Cao. The challenge of maintaining microscopist capacity at basic levels for malaria elimination in Jiangsu Province, China. BMC Public Health 2018; 18(1): 489
https://doi.org/10.1186/s12889-018-5307-y pmid: 29650008
19 Ministry of Health, the People’s Republic of China. Diagnostic Criteria for Malaria (WS 259-2006). 2006 (in Chinese)
20 National Health and Planning of the People’s Republic of China. Diagnosis of malaria (WS 259-2015). 2015 (in Chinese)
21 National Health and Planning of the People’s Republic of China. Microscopic examination of blood films for malaria parasites (WS/T 569-2017). 2017 (in Chinese)
22 Q Fu, SZ Li, Q Wang, L Zhang, W Liu, X Zheng, SS Zhang, ZG Xia, SS Zhou, Z Chen, LY Wang, XN Zhou. Report of analysis of National Technique Competition for Diagnosis of Parasitic Diseases in 2011—II Analysis of capabilities of Plasmodium detection. Chin J Parasitol Parasit Dis (Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi) 2012; 24(3): 274–278 (in Chinese)
pmid: 23012948
23 Y Ruan, T Tian, Z Zhu, Y Hao, L Zhang, T Zhu, L Wang, Q Wang, C Cao, S Li, X Zhou. Assessing competence for helminthiases: a lesson learnt from national contest of parasitic diseases in China in 2012–2016. Acta Trop 2019; 198: 105078
https://doi.org/10.1016/j.actatropica.2019.105078 pmid: 31299284
24 M Li, H Zhou, H Yan, J Yin, X Feng, Z Xia, S Zhou. Analysis on external competency assessment for malaria microscopists in China. Malar J 2019; 18(1): 366
https://doi.org/10.1186/s12936-019-2996-3 pmid: 31727074
25 WHO. Malaria microscopy quality assurance manual (Version 1). Geneva: World Health Organization, ‎2009
26 WHO. Malaria microscopy quality assurance manual (Version 2). Geneva: World Health Organization, ‎2016
27 J Yin, H Yan, M Li, W Fang, F Huang, W Jiang, S Zhou, Z Xia. Malaria diagnosis reference laboratory: analysis of malaria detecting ability under microscope in the External Quality Assurance Program. Int J Med Parasit Dis (Guo Ji Yi Xue Ji Sheng Chong Bing Za Zhi) 2015; 42(3): 173–175 (in Chinese)
28 JA Cunningham, RM Thomson, SC Murphy, M de la Paz Ade, XC Ding, S Incardona, E Legrand, NW Lucchi, D Menard, SL Nsobya, AC Saez, PL Chiodini, J Shrivastava. WHO malaria nucleic acid amplification test external quality assessment scheme: results of distribution programmes one to three. Malar J 2020; 19(1): 129
https://doi.org/10.1186/s12936-020-03200-0 pmid: 32228615
29 L Fei, Z Shuang, Y Yi, L Shan-Shan, T Yan, X Jing-Ru, Z Yang. Assessment of malaria microscopy competency at primary health institutions in the Chongqing Municipality. Front Med (Lausanne) 2021; 8: 602442
https://doi.org/10.3389/fmed.2021.602442 pmid: 33791321
30 Y Dong, XH Mao, MN Chen, Y Deng, J Wang, YC Xu. Quality analysis of laboratory malaria diagnosis in Yunnan Province during 2012–2014. Chin J Parasitol Parasit Dis (Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi) 2015; 33(3): 191–195 (in Chinese)
pmid: 26541035
31 DY She, JH Wu, LD Lu, YT Huang, Y Geng, NH Zhang. Evaluation of the testing ability of city/prefecture-level malaria laboratories in Guizhou Province during 2014–2016. Chin J Parasitol Parasit Dis (Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi) 2017; 35(5): 466–471 (in Chinese)
32 LC Sun, DN Wu, XR Dong, Z Tu, W Lin, J Xia. Results of Hubei provincial malaria diagnostic reference laboratory from 2014 to 2018. Chin J Dis Control Prev (Zhonghua Ji Bing Kong Zhi Za Zhi) 2021; 25(1): 108–112 (in Chinese)
33 Y Deng, Y Dong, YC Xu, XH Mao, MN Chen. Quality and impact factors of malaria diagnosis in Yunnan provincial laboratory from 2015 to 2016. Chin J Zoonoses (Zhongguo Ren Shou Gong Huan Bing Xue Bao) 2018; 34(4): 337–342 (in Chinese)
34 LC Sun, XR Dong, Z Tu, DN Wu, W Lin, XR Zhou, H Zhu. Re-examination of malaria diagnosis in Hubei provincial malaria diagnostic reference laboratory from 2017 to 2019. Chin J Schisto Control (Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi) 2020; 32(6): 631–634 (in Chinese)
pmid: 33325200
35 S Xu, YP Gu, YY Cao, WM Wang, JX Tang, JL Li, MH Zhang, HY Zhou, GD Zhu, J Cao. Results analysis of Jiangsu provincial malaria diagnostic reference laboratory in 2017. Chin J Schisto Control (Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi) 2018; 30(6): 630–634 (in Chinese)
36 National Institute of Parasitic Diseases, China CDC. The national quality assessment of malaria blood smear preparation and microscopic examination, 2020. (in Chinese) (accessed December 25, 2020)
37 L Zhang, J Feng, SS Zhang, ZG Xia, SS Zhou. Epidemiological characteristics of malaria and the progress towards its elimination in China in 2018. Chin J Parasitol Parasit Dis (Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi) 2019; 37(3): 241–247 (in Chinese)
38 L Zhang, J Feng, ZG Xia, SS Zhou. Epidemiological characteristics of malaria and progress on its elimination in China in 2019. Chin J Parasitol Parasit Dis (Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi) 2020; 38(2): 133–138 (in Chinese)
39 L Zhang, J Feng, H Tu, J Yin, ZG Xia. Malaria epidemiology in China in 2020. Chin J Parasitol Parasit Dis (Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi) 2021; 39(2): 195–199 (in Chinese)
40 L Ayong, CEE Moukoko, WF Mbacham. Diagnosing malaria: methods, tools, and field applicability. Methods Mol Biol 2019; 2013: 73–82
https://doi.org/10.1007/978-1-4939-9550-9_5 pmid: 31267494
41 T Bousema, L Okell, I Felger, C Drakeley. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol 2014; 12(12): 833–840
https://doi.org/10.1038/nrmicro3364 pmid: 25329408
42 J Cheaveau, DC Mogollon, MAN Mohon, L Golassa, D Yewhalaw, DR Pillai. Asymptomatic malaria in the clinical and public health context. Expert Rev Anti Infect Ther 2019; 17(12): 997–1010
https://doi.org/10.1080/14787210.2019.1693259 pmid: 31718324
43 D Gamboa, MF Ho, J Bendezu, K Torres, PL Chiodini, JW Barnwell, S Incardona, M Perkins, D Bell, J McCarthy, Q Cheng. A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS One 2010; 5(1): e8091
https://doi.org/10.1371/journal.pone.0008091 pmid: 20111602
44 WHO. False-negative RDT results and implications of new reports of P. falciparum histidine-rich protein 2/3 gene deletions. Geneva: World Health Organization, 2017
45 R Thomson, JB Parr, Q Cheng, S Chenet, M Perkins, J Cunningham. Prevalence of Plasmodium falciparum lacking histidine-rich proteins 2 and 3: a systematic review. Bull World Health Organ 2020; 98(8): 558–568F
https://doi.org/10.2471/BLT.20.250621 pmid: 32773901
46 The State Council of the People’s Republic of China. Notice on the Work Plan for Further Promoting the Capacity Building of the COVID-19 Nucleic Acid Amplification Testing Issued by the State Council’s Joint Prevention and Control Mechanism in Response to the COVID-19. (in Chinese) (accessed August 31, 2020)
47 L Zhang, H Tu, S Zhou, Z Xia, J Feng. Malaria deaths—China, 2011–2020. China CDC Wkly 2021; 3(17): 360–365
https://doi.org/10.46234/ccdcw2021.098 pmid: 34594884
48 W Li, T Zhang, X Xu, J Jiang, C Yu, C Tian, S Wang, X Lyu, Z Liu. Problems associated with the diagnosis of imported malaria in Anhui Province, China. Am J Trop Med Hyg 2020; 102(1): 142–146
https://doi.org/10.4269/ajtmh.19-0471 pmid: 31701862
49 LQ Fang, Y Sun, GP Zhao, LJ Liu, ZJ Jiang, ZW Fan, JX Wang, Y Ji, MJ Ma, J Teng, Y Zhu, P Yu, K Li, YJ Tian, WC Cao. Travel-related infections in mainland China, 2014–16: an active surveillance study. Lancet Public Health 2018; 3(8): e385–e394
https://doi.org/10.1016/S2468-2667(18)30127-0 pmid: 30033200
50 WMKTAW Gunasekera, R Premaratne, D Fernando, M Munaz, MGY Piyasena, D Perera, R Wickremasinghe, KDNP Ranaweera, K Mendis. A comparative analysis of the outcome of malaria case surveillance strategies in Sri Lanka in the prevention of re-establishment phase. Malar J 2021; 20(1): 80
https://doi.org/10.1186/s12936-021-03621-5 pmid: 33563273
[1] Ruijie Chang, Huwen Wang, Shuxian Zhang, Zezhou Wang, Yinqiao Dong, Lhakpa Tsamlag, Xiaoyue Yu, Chen Xu, Yuelin Yu, Rusi Long, Ning-Ning Liu, Qiao Chu, Ying Wang, Gang Xu, Tian Shen, Suping Wang, Xiaobei Deng, Jinyan Huang, Xinxin Zhang, Hui Wang, Yong Cai. Phase- and epidemic region-adjusted estimation of the number of coronavirus disease 2019 cases in China[J]. Front. Med., 2020, 14(2): 199-209.
[2] Honglu Zhou, Songmei Wang, Lorenz von Seidlein, Xuanyi Wang. The epidemiology of norovirus gastroenteritis in China: disease burden and distribution of genotypes[J]. Front. Med., 2020, 14(1): 1-7.
[3] Chongguang Yang, Qian Gao. Recent transmission of Mycobacterium tuberculosis in China: the implication of molecular epidemiology for tuberculosis control[J]. Front. Med., 2018, 12(1): 76-83.
[4] Jikai Liu, Li Bai, Weiwei Li, Haihong Han, Ping Fu, Xiaochen Ma, Zhenwang Bi, Xiaorong Yang, Xiuli Zhang, Shiqi Zhen, Xiaoling Deng, Xiumei Liu, Yunchang Guo. Trends of foodborne diseases in China: lessons from laboratory-based surveillance since 2011[J]. Front. Med., 2018, 12(1): 48-57.
[5] Min Chen, Yuan Xu, Nan Hong, Yali Yang, Wenzhi Lei, Lin Du, Jingjun Zhao, Xia Lei, Lin Xiong, Langqi Cai, Hui Xu, Weihua Pan, Wanqing Liao. Epidemiology of fungal infections in China[J]. Front. Med., 2018, 12(1): 58-75.
[6] Chun Chen,Zhihong Cheng,Ping Jiang,Mei Sun,Qi Zhang,Jun Lv. Effect of the new maternity insurance scheme on medical expenditures for caesarean delivery in Wuxi, China: a retrospective pre/post-reform case study[J]. Front. Med., 2016, 10(4): 473-480.
[7] Huiqin Zhong,Ya Shao,Ling Fan,Tangshen Zhong,Lu Ren,Yan Wang. Perceived resource support for chronic illnesses among diabetics in north-western China[J]. Front. Med., 2016, 10(2): 219-227.
[8] Xijin Xu,Xiang Zeng,H. Marike Boezen,Xia Huo. E-waste environmental contamination and harm to public health in China[J]. Front. Med., 2015, 9(2): 220-228.
[9] Runshun Zhang,Yinghui Wang,Baoyan Liu,Guangli Song,Xuezhong Zhou,Shizhen Fan,Xishui Pan. Clinical data quality problems and countermeasure for real world study[J]. Front. Med., 2014, 8(3): 352-357.
[10] Lizhe Ai, Yaqin Yu, Xiaoli Liu, Chong Wang, Jieping Shi, Hui Sun, Qiong Yu. Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China?[J]. Front Med, 2014, 8(1): 113-117.
[11] Xiangwei Li, Yu Yang, Jianmin Liu, Feng Zhou, Wei Cui, Ling Guan, Fei Shen, Cong Gao, Mufei Li, Qi Jin, Lei Gao. Treatment outcomes of pulmonary tuberculosis in the past decade in the mainland of China: a meta-analysis[J]. Front Med, 2013, 7(3): 354-366.
[12] Wei Li, Shan Lu, Zhigang Cui, Jinghua Cui, Haijian Zhou, Yiqing Wang, Zhujun Shao, Changyun Ye, Biao Kan, Jianguo Xu. PulseNet China, a model for future laboratory-based bacterial infectious disease surveillance in China[J]. Front Med, 2012, 6(4): 366-375.
[13] Kai Gao, Junzhi Wang. The biopharmaceutical industry in China: history and future perspectives[J]. Front Med, 2012, 6(2): 101-111.
[14] Zhiping Yang, Qiong Wu, Kaichun Wu, Daiming Fan. Scientific publications on systematic review and meta-analysis from Chinese authors: a 10-year survey of the English literature[J]. Front Med, 2012, 6(1): 94-99.
[15] Huimin Gao, Zhimin Wang, Yujuan Li, Zhongzhi Qian. Overview of the quality standard research of traditional Chinese medicine[J]. Front Med, 2011, 5(2): 195-202.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed